Why Did the FALCON Clinical Trial End?

Why Did the FALCON Clinical Trial End?

Published on May 23, 2023 | On May 10, the ongoing FALCON clinical trial was terminated early. FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with ADPKD. The study aimed for...
3 Questions About Virtual Advocacy Day 2023

3 Questions About Virtual Advocacy Day 2023

Published on May 11, 2023 | Last month, PKD advocates from coast to coast participated in Virtual Advocacy Day 2023. Through virtual meetings, patients, friends, researchers, and PKD Foundation staff united to share our community’s needs with Congress. For those...